A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/437 (2006.01) A61K 31/00 (2006.01) A61K 31/438 (2006.01) A61K 31/444 (2006.01) A61K 31/4985 (2006.01) A61K 31/55 (2006.01) A61K 38/05 (2006.01) A61K 45/06 (2006.01) A61P 1/04 (2006.01) A61P 1/10 (2006.01)
Patent
CA 2350857
Disclosed are medicines for treating systemic lupus erythematosus and/or inflammatory bowel disease such as Crohn's disease or ulcerative colitis, which comprise a growth hormone secretagogue (GHS), prodrug thereof or a pharmaceutically acceptable salt of the GHS or the prodrug. More particularly, the GHS is a compound of the Formula I: (see formula I) (in which HET is a heterocyclic moiety; R3 is alkyl, etc.; R4 is H, alkyl, etc.; X4 is H or alkyl; R6 is bond, alkylene, etc.; R7 and R8 are each H, alkyl, etc.) or a prodrug thereof or a pharmaceutically acceptable salt of the GHS or the prodrug. Also disclosed are combinations of a GHS and a second therapeutic agent, where the second therapeutic agent is known to be beneficial in the treatment of systemic lupus erythematosus and/or inflammatory bowel disease such as Crohn's disease or ulcerative colitis; and kits and pharmaceutical compositions comprising such combinations.
Busch Frank Robert
Lefker Bruce Allen
Pan Lydia Codetta
Pfizer Products Inc.
Smart & Biggar
LandOfFree
The use of growth hormone secretagogues to treat systemic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with The use of growth hormone secretagogues to treat systemic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of growth hormone secretagogues to treat systemic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2074287